Palacios MP, Cepeda JM, Arellano EJM

Language: Spanish
References: 20
Page: 342-346
PDF size: 182.57 Kb.

ABSTRACT

The myxedema is the most severe complication of hypothyroidism that can be manifested in various organs and systems. The most common cause is associated with nutritional deficiencies, immune, infection or drugs, diagnostic keys are neurological deficit and a thyroid profile with elevated thyroid stimulating hormone, sometimes endotracheal intubation for respiratory failure is necessary. The treatment involves correcting the hormonal deficit and give supportive care when the patient is intubated. We report a patient with a psychiatric history treated with anti-psychotic drugs, which debuts with an intestinal occlusion was managed conservatively, while staying anti-psychotic treatment is restarted and presents data of respiratory insufficiency leading to intubate thus entering at Intensive Care Unit. Thyroid enzymes were processed had high titles of Stimulating Hormone Thyroid gave manage thyroid and steroid hormones according to the current literature, evolving favorably neurologically and accomplished Protocol of Weaning succesful, go out two weeks of their income.

REFERENCES

1. Sara B, Ryan S. Hypothyroidism. Causes, killers, and life saving treatments. Emerg Med Clin N Am. 2014;32:303-317.

2. Flynn RW, MacDonald TM, Morris AD, Jung RT, Leese GP. The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population. J Clin Endocrinol Metab. 2004;89(8):3879-3884.

3. Hollowell J, Staehling N, Flanders W, Hannon WH, Gunter EW, Spencer C, et al. Serum TSH, T4, and thyroid antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.

4. Vaidya B, Pearce SH. Management of hypothyroidism in adults. BMJ. 2008;337:a801.

5. Kwaku MP, Burman KD. Myxedema coma. J Intensive Care Med. 2007;22:224-231.

6. Massumi RA, Winnacker JL. Severe depression of the respiratory center in myxedema. Am J Med. 1964;36:876-882.

7. Gupta KJ. Myxedema coma: a sleeping giant in clinical practice. Am J Med. 2013;126(12):e3-4.

8. Gardner DG. Endocrine emergencies. In: Gardner DG, Shoback D, Eds., Greenspan’s Basic and Clinical Endocrinology, 8th edition, McGraw-Hill, New York, NY, USA, 2007.

9. Ladenson PW, Goldenheim PD, Ridgway EC. Prediction and reversal of blunted ventilatory responsiveness in patients with hypothyroidism. Am J Med. 1988;84(5):877-883.

10. Wilson WR, Bedell GN. The pulmonary abnormalities in myxedema. J Clin Invest. 1960;39:42-55.

11. Skowsky WR, Kikuchi TA. The role of vasopressin in the impaired water excretion of myxedema. Am J Med. 1978;64(4):613-621.

12. Weirsinga WM. Hypothyroidism and myxedema coma. In: Jameson JL, Legroot LJ, eds. Endocrinology adult and pediatric. Saunders, 6th edition, Philadelphia, Pa. USA, 2010.

13. Surks MI, Sievert R. Drug and thyroid function. N Engl J Med. 1995;333(25):1688-1694.

14. Church CO, Callen EC. Myxedema coma associated with combination aripiprazole and sertraline therapy. Ann Pharmacother. 2009;43(12):2113-2116.

15. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501-509.

16. Coceani M. Heart disease in patients with thyroid dysfunction: hyperthyroidism, hypothyroidism and beyond. Anadolu Kardiyol Derg. 2013;12(1):62-66.

17. Arlot S, Debussche X, Lalau JD, Mesmacque A, Tolani M, Quichaud J, et al. Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment. Intensive Care Med. 1991;17:16-18.

18. Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med. 1993;119:492-502.

19. Yamamoto T, FukuyamaJ, Fujiyoshi A. Factors associated with mortality of myxedema coma: report of eight cases and literature survey. Thyroid. 1999;9(12):1167-1174.

20. Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Physician. 2000; 62(11):2485-2490.